Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration

Cancer Science

Volumn 100, Issue 2, 2009, Pages 261-268

  Winklmeier, Andreas ^a   Contreras Shannon, Veronica ^b   Arndt, Stephanie ^a   Melle, Christian ^c   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b University of Texas Health Science Center   (United States)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CADHERIN 7; CELL PROTEIN; MELANOMA INHIBITORY ACTIVITY PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA; MELANOMA CELL; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; MELANOMA; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURFACE PLASMON RESONANCE; TUMOR CELLS, CULTURED;

EID: 58549084396     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01048.x     Document Type: Article

References (27)

1. Blesch A, Bosserhoff AK, Apfel R et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 1994; 54: 5695-701.
2. Bosserhoff AK, Echtenacher B, Hein R, Buettner R. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo. Melanoma Res 2001; 11: 417-21.
3. Bosserhoff AK, Kaufmann M, Kaluza B et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997; 57: 3149-53.
4. Bosserhoff AK. Melanoma inhibitory activity (MIA): An important molecule in melanoma development and progression. Pigment Cell Res 2005; 18: 411-6.
5. Bauer R, Humphries M, Fassler R, Winklmeier A, Craig SE, Bosserhoff AK. Regulation of integrin activity by MIA. J Biol Chem 2006; 281: 11669-77.
6. Hsu MY, Wheelock MJ, Johnson KR, Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Invest Dermatol Symp Proc 1996; 1: 188-94.
7. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
8. Gumbiner BM. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-57.
9. Chu YS, Eder O, Thomas WA et al. Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains. J Biol Chem 2006; 281: 2901-10.
10. Becker T, Redies C. Internal structure of the nucleus rotundus revealed by mapping cadherin expression in the embryonic chicken visual system. J Comp Neurol 2003; 467: 536-48.
11. Luo J, Treubert-Zimmermann U, Redies C. Cadherins guide migrating Purkinje cells to specific parasagittal domains during cerebellar development. Mol Cell Neurosci 2004; 25: 138-52.
12. Kools P, Van Imschoot G, van Roy F. Characterization of three novel human cadherin genes (CDH7, CDH19, and CDH20) clustered on chromosome 18q22-q23 and with high homology to chicken cadherin-7. Genomics 2000; 68: 283-95.
13. Moore R, Champeval D, Denat L et al. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 2004; 23: 6726-35.
14. Nakagawa S, Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 1998; 125: 2963-71.
15. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005; 65: 448-56.
16. Arndt S, Bosserhoff AK. TANGO is a tumor suppressor of malignant melanoma. Int J Cancer 2006; 119: 2812-20.
17. Lehmann R, Melle C, Escher N, von Eggeling F. Detection and identification of protein interactions of S100 proteins by ProteinChip technology. J Proteome Res 2005; 4: 1717-21.
18. Melle C, Osterloh D, Ernst G, Schimmel B, Bleul A, von Eggeling F. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry. Int J Mol Med 2005; 16: 11-7.
19. Nakagawa S, Takeichi M. Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 1995; 121: 1321-32.
20. Bosserhoff AK, Moser M, Buettner R. Characterization and expression pattern of the novel MIA homolog TANGO. Gene Expr Patterns 2004; 4: 473-9.
21. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7: 619-27.
22. Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001; 276: 24661-6.
23. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002; 34: 255-68.
24. Feltes CM, Kudo A, Blaschuk O, Byers SW. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 2002; 62: 6688-97.
25. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-90.
26. Kuphal S, Poser I, Jobin C, Hellerbrand C, Bosserhoff AK. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 2004; 23: 8509-19.
27. Poser I, Golob M, Buettner R, Bosserhoff AK. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 2003; 23: 2991-8.